With a $50 million initial investment from Flagship, Terrana will use RNA from benign plant viruses as a chassis to carry ...

With Terrana Biosciences, Moderna founder Flagship can apply its RNA knowledge to agricultural use cases like pest and ...

The RNAi Technology Market offers growth opportunities in drug development, gene therapy, and agriculture due to RNAi's precision in gene silencing. Key drivers include the rising demand for RNAi ...

While biopharmaceutical technologies have made substantial strides in treating diseases, drug research and development ...

The use of RNAi technology to combat some of our most challenging diseases offers a biological solution that is evidence-based and environmentally friendly. Because it could help to save the world’s ...

The innate immune system is the body's first line of defense against pathogens and foreign substances. An essential component ...

Global Antisense and RNAi therapeutics Market is valued approximately at USD 3.69 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 18.72% over the forecast period ...

Queensland Alliance for Agriculture and Food Innovation Research Fellow Dr. Karishma Mody and Ph.D. candidate Yunjia Yang are using the innovative RNA technology to combat sheep blowfly, a major ...

Atalanta Therapeutics has technology that delivers RNA interference (RNAi) therapies into the CNS. The startup has spent the past four years quietly working on its technology and potential drugs.

A quick glance through PubMed reveals how broadly RNAi screening technology is now being applied—screens to profile cell division in cultured human cells 1, to identify host factors important in ...

The RNAi Technology Market offers growth opportunities in drug development, gene therapy, and agriculture due to RNAi's precision in gene silencing. Key drivers include the rising demand for RNAi ...